Related Experiment Video
Updated: Aug 10, 2026
Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
Published on: July 29, 2010
Functional impact of concomitant versus alternative defects in the Chk2-p53 tumour suppressor pathway
J Falck1, C Lukas, M Protopopova
1Danish Cancer Society, Institute of Cancer Biology, Strandboulevarden 49, DK-2100 Copenhagen Ø, Denmark.
Abstract:
Recent evidence identified a genetic and functional link between Chk2 kinase and p53 as a candidate genome integrity checkpoint and a tumour suppressor pathway. Here we report that in human cells, Chk2 and p53 form protein-protein complexes whose abundance increased upon DNA damage, and whose formation was abrogated through cancer associated mutations in the FHA domain of Chk2, or mutations in the tetramerization domain of p53. Whereas among Li-Fraumeni syndrome families mutations of Chk2 or p53 occur in a mutually exclusive manner, we document that the colon cancer cell line HCT-15 concomitantly lacks functions of both Chk2 and p53, the latter demonstrated by a non-invasive reporter assay monitoring p53-dependent transactivation in live cells. Despite the preserved ability of common cancer-derived mutant p53 proteins to bind and potentially 'titrate' activated Chk2, the integrity of the S phase checkpoint response to ionizing radiation remained largely intact and dependent on Chk2 in cells with wild-type, mutant, or no p53. These results provide new mechanistic insights into the Chk2-p53 interplay, suggest how mutations in Chk2 may abrogate its tumour suppressor function, and indicate that compared with individual defects in either Chk2 or p53, concomitant mutations in both of these cell cycle checkpoint regulators may provide some additional selective advantage to tumour cells.
Insights
The study reveals that Chk2 kinase and p53 form complexes that are disrupted by cancer mutations. Concomitant defects in both Chk2 and p53 may offer tumor cells a selective advantage.
Area of Science:
- Cellular Biology
- Molecular Oncology
- Genetics
Background:
- The Chk2 kinase and p53 tumor suppressor pathway are critical for genome integrity.
- Understanding their interplay is crucial for cancer research.
Purpose of the Study:
- To investigate the functional and genetic link between Chk2 kinase and p53 in human cells.
- To elucidate the impact of cancer-associated mutations on Chk2-p53 interactions and cellular responses to DNA damage.
Main Methods:
- Protein-protein complex formation assays upon DNA damage.
- Analysis of cancer-associated mutations in Chk2 (FHA domain) and p53 (tetramerization domain).
- Functional assessment of p53 activity using a live-cell reporter assay.
- Evaluation of the S phase checkpoint response to ionizing radiation in cells with varying p53 and Chk2 status.
Main Results:
- Chk2 and p53 form DNA damage-inducible protein complexes, disrupted by specific cancer mutations.
- Colon cancer cell line HCT-15 exhibits loss of function for both Chk2 and p53.
- Mutant p53 retains binding to Chk2, but the S phase checkpoint remains largely intact and Chk2-dependent, irrespective of p53 status.
- Concomitant defects in Chk2 and p53 may confer a selective advantage to tumor cells.
Conclusions:
- Mutations in Chk2 can abrogate its tumor suppressor function.
- The Chk2-p53 interplay is complex, with Chk2 maintaining checkpoint integrity even in the absence of functional p53.
- Combined deficiencies in Chk2 and p53 might enhance tumor cell survival and proliferation.
Related Concept Videos
01:36Mismatch Repair
02:36DNA Damage can Stall the Cell Cycle
02:23Abnormal Proliferation
01:19Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
01:20Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
02:36DNA Damage Can Stall the Cell Cycle